Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased expression of GAD2 mRNA | decreases expression | 14967907
|
D005680 |
gamma-Aminobutyric Acid |
GAD2 protein results in increased chemical synthesis of gamma-Aminobutyric Acid | increases chemical synthesis | 9634146
|
D005680 |
gamma-Aminobutyric Acid |
GAD2 protein results in increased chemical synthesis of gamma-Aminobutyric Acid | increases chemical synthesis | 15368537
|
D005680 |
gamma-Aminobutyric Acid |
GAD2 protein results in increased chemical synthesis of gamma-Aminobutyric Acid | increases chemical synthesis | 12376704
|
D005680 |
gamma-Aminobutyric Acid |
GAD2 protein results in increased chemical synthesis of gamma-Aminobutyric Acid | increases chemical synthesis | 12634427
|
D000625 |
Aminooxyacetic Acid |
Aminooxyacetic Acid results in decreased activity of GAD2 protein | decreases activity | 12634427
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GAD2 mRNA | affects expression | 16483693
|
C027423 |
aroclor 1242 |
[aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of GAD2 protein | affects cotreatment|decreases expression | 17324953
|
C028617 |
aroclor 1248 |
[aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of GAD2 protein | affects cotreatment|decreases expression | 17324953
|
C026987 |
aroclor 1260 |
[aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of GAD2 protein | affects cotreatment|decreases expression | 17324953
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
[aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of GAD2 protein | affects cotreatment|decreases expression | 17324953
|
D003024 |
Clozapine |
Clozapine results in increased expression of GAD2 mRNA | increases expression | 17266109
|
D003024 |
Clozapine |
Clozapine results in increased expression of GAD2 mRNA | increases expression | 18923069
|
D003042 |
Cocaine |
Cocaine affects the expression of GAD2 protein | affects expression | 15722053
|
D003975 |
Diazepam |
Diazepam results in decreased expression of GAD2 mRNA | decreases expression | 15802192
|
D004051 |
Diethylhexyl Phthalate |
Diethylhexyl Phthalate results in decreased expression of GAD2 mRNA | decreases expression | 15620428
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of GAD2 mRNA | decreases expression | 12807726
|
D007980 |
Levodopa |
Levodopa results in increased expression of GAD2 mRNA | increases expression | 15837143
|
D004958 |
Estradiol |
Estradiol results in increased expression of GAD2 mRNA | increases expression | 15677881
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GAD2 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GAD2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAD2 mRNA | affects cotreatment|increases expression | 17942748
|
D005033 |
Ethylmaleimide |
Ethylmaleimide results in decreased activity of GAD2 protein | decreases activity | 15836621
|
D005473 |
Fluoxetine |
Fluoxetine results in increased expression of GAD2 protein | increases expression | 19359144
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of GAD2 mRNA | decreases expression | 18923069
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of GAD2 protein | decreases expression | 19359144
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of GAD2 mRNA | increases expression | 18923069
|
C029424 |
hydrazine |
hydrazine results in decreased activity of GAD2 protein | decreases activity | 12634427
|
D006854 |
Hydrocortisone |
Hydrocortisone results in increased expression of GAD2 protein | increases expression | 15531528
|
C049985 |
K 252 |
K 252 results in decreased expression of GAD2 mRNA | decreases expression | 12859332
|
C049985 |
K 252 |
K 252 results in decreased expression of GAD2 protein | decreases expression | 12859332
|
D015097 |
3-Mercaptopropionic Acid |
3-Mercaptopropionic Acid results in decreased activity of GAD2 protein | decreases activity | 4154755
|
D008694 |
Methamphetamine |
Methamphetamine results in increased expression of GAD2 mRNA | increases expression | 15601951
|
C025256 |
nonylphenol |
nonylphenol results in decreased expression of GAD2 mRNA | decreases expression | 15620428
|
C076029 |
olanzapine |
olanzapine results in decreased expression of GAD2 protein | decreases expression | 19359144
|
D010433 |
Pentylenetetrazole |
GAD2 gene mutant form results in increased susceptibility to Pentylenetetrazole | increases response to substance | 8954991
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of GAD2 mRNA | increases expression | 17266109
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of GAD2 mRNA | increases expression | 12807726
|
C033457 |
phenobarbital quinidine |
phenobarbital quinidine results in decreased expression of GAD2 mRNA | decreases expression | 15802192
|
D010852 |
Picrotoxin |
GAD2 gene mutant form results in increased susceptibility to Picrotoxin | increases response to substance | 8954991
|
D010852 |
Picrotoxin |
Picrotoxin results in increased expression of GAD2 mRNA | increases expression | 15170462
|
D010852 |
Picrotoxin |
Picrotoxin results in increased expression of GAD2 protein | increases expression | 15382257
|
D010862 |
Pilocarpine |
Pilocarpine affects the expression of GAD2 protein | affects expression | 15857427
|
D010862 |
Pilocarpine |
Pilocarpine results in increased expression of GAD2 protein | increases expression | 15987249
|
D011732 |
Pyridoxal Phosphate |
Pyridoxal Phosphate binds to GAD2 protein | affects binding | 15690345 15686475 15836621
|
D011732 |
Pyridoxal Phosphate |
Pyridoxal Phosphate binds to GAD2 protein modified form | affects binding | 15686475
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of GAD2 mRNA | decreases expression | 20308225
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of GAD2 mRNA | increases expression | 20376865
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of GAD2 mRNA | affects expression | 17555576
|
D043343 |
Testosterone Propionate |
Testosterone Propionate results in increased expression of GAD2 mRNA | increases expression | 14967907
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAD2 mRNA | affects cotreatment|increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of GAD2 mRNA | increases expression | 11841568
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of GAD2 protein | increases expression | 15379904
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of GAD2 mRNA | decreases expression | 19359144
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.13 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Diethylhexyl Phthalate |
17.04 | 6734493 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
17.04 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
17.04 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
17.04 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.56 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.15 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.53 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.83 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.61 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
14.99 | 16434500 19052882 18056438 17620307 17162532 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
14.99 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.99 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.28 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.49 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.66 | 14617031 12649775 16160616 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.29 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.82 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.60 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Diazepam |
13.33 | 16284244 18313124 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
13.33 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
13.33 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.07 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.35 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.35 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.16 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.21 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
2.69 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.69 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.69 | 18685284 17069543 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.69 | 17507914 18940202 18985861 16609825 18316065 19460635 15238991 17157402 18558336 19232924 20603192 17688650 18177632 18775368 18396377 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.02 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.86 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.73 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
7.73 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.38 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.14 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.14 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.18 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.18 | 19861407 17018787 17289903 16675129 17261762 18497071 12948864 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.18 | 18821012 19084267 18997820 20544844 19244106 16202921 11161223 19189210 18351453 18855134 20065188 19142967 16818667 19189212 19155303 15668708 20135344 19221464 19059307 18629630 19487384 18815881 19410462 17893378 19289846 19011961 21138602 15565566 18425577 20859285 19200415 20005174 17242785 19288272 19115204 16273361 17440819 19103187 17261762 21152245 20390343 18984771 16873071 17049068 19066611 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.18 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.18 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.18 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.06 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.48 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.11 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.74 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
10.37 | 18788625 17138121 16878318 17978847 16502159 21159647 19052882 19822196 16328049 20007298 16288022 16779866 20514400 19171122 18506893 19539802 18056438 16698587 17761372 11831363 16569478 20101231 18210153 20084675 16681979 19394651 19383236 19335982 10672840 18978308 19107877 3581430 20727157 19418558 20214788 17428255 19208518 20512989 16935385 18785209 18393292 16807293 18691550 20935162 17055752 18971187 17173139 10737359 20432363 16540662 19701751 16830150 3084413 20524982 19919837 18665156 18494052 19519916 17162532 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.37 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
10.37 | 17173139 1701930 20007298 6705139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.37 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.37 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.37 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.25 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.25 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.26 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.14 | 18850075 18670907 16120746 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.50 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.85 | 17460283 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.83 | 18071103 16772815 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
9.58 | 17174075 2727394 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
9.58 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.58 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.85 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.18 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.55 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.19 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.57 | 17110522 17681005 17333356 16919318 15861022 16105132 11677210 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.74 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Diazepam |
12.72 | 3629520 |
MESH:D002972 |
Cleft Palate |
|
Hydrocortisone |
12.72 | 15826874 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
12.72 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
12.72 | 9407595 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.31 | 19606084 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.57 | 17123785 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.31 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.72 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Hydrocortisone |
5.03 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.03 | 20055451 15322242 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.03 | 9664655 10589399 8800419 17551590 9125849 16925845 9211117 9142499 9224671 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.03 | 16575769 17688650 8888407 |
MESH:D003643 |
Death |
|
Pentylenetetrazole |
6.33 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.47 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.22 | 11575062 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.96 | 19031437 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
4.31 | 15014590 |
MESH:D003876 |
Dermatitis, Atopic |
|
Diethylhexyl Phthalate |
3.85 | 16882537 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.42 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
6.50 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.50 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.50 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.71 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
7.71 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Hydrocortisone |
4.34 | 7237001 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.14 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
aroclor 1260 |
10.62 | 6156243 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
10.62 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
10.62 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
10.62 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
10.62 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.46 | 11462148 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
Levodopa |
5.95 | 3690436 15893579 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.89 | 16402076 |
MESH:D004421 |
Dystonia |
|
Diazepam |
15.73 | 1851702 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
15.73 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
15.73 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
6.05 | 12798668 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.05 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.56 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.56 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.67 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.67 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.86 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.86 | 16202921 17893378 19155303 20544844 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.86 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.67 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
9.47 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
9.47 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Diazepam |
14.64 | 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
14.64 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
14.64 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Diazepam |
14.10 | 821787 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
14.10 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Pilocarpine |
14.10 | 11162239 19439326 19700373 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
14.10 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Diazepam |
18.58 | 6426943 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Pentylenetetrazole |
18.58 | 6426943 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
18.58 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
18.58 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
9.98 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
9.98 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.13 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
9.13 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.70 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.83 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.83 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
15.80 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.80 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.80 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
15.80 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.98 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.06 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.47 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.75 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.12 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.78 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.30 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
7.30 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.27 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.74 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.18 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.91 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.74 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.79 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
5.79 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.97 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
7.13 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.13 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.62 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.82 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.16 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
9.16 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.46 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.63 | 15340226 16959395 8697196 18606429 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
2.90 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.17 | 16778211 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Levodopa |
5.36 | 16275827 16787708 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
10.47 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
10.47 | 17658665 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.82 | 17933447 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.75 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.41 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.09 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.73 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.73 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.19 | 18785209 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
10.19 | 12798668 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.19 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.19 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.70 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.37 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.72 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.72 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.31 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.31 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.30 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.30 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.56 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.34 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.60 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.60 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.88 | 17301526 9834237 17217047 19035177 19225113 16823087 12679006 17339181 17649720 17294898 16140955 19075265 15748426 16788101 16935935 17361223 17368321 17107899 17506722 16891316 16766008 19642359 16331271 17712046 19029980 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.02 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
11.69 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
11.69 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
11.69 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.87 | 18665156 18407596 20032147 19638242 18522880 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
5.87 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.46 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.46 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.46 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
4.46 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.71 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.71 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylhexyl Phthalate |
15.80 | 11940454 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
15.80 | 19426721 19551842 18644402 10737359 18648771 20492335 20118626 21071580 12771043 2862719 15175105 19642983 19294768 20501860 19812893 21167192 21278145 9163691 15885732 21047994 20101389 2422723 18978307 19090486 18977376 19850985 18754104 19256749 20137499 20434301 20452335 19996281 19638242 19255062 19254457 20583210 19499222 20405173 19073162 16942905 12112319 19427195 19690152 19833225 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
15.80 | 19482888 21047994 15975961 19073162 8742319 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
15.80 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
15.80 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
15.80 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
8.31 | 18093689 18544905 19126423 16267830 18308698 18079962 17854601 19539802 16842330 19004024 17942915 19009564 9362446 18775883 17174075 3124819 2563599 21159647 19519916 18282651 18253720 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
8.31 | 6150874 1399818 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.31 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.42 | 20210726 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.90 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.85 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.37 | 20970405 21163286 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.37 | 17306315 19931552 16712894 17077188 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.37 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.37 | 11884234 19555203 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.36 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.10 | 11408345 17203775 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.10 | 14580682 19196723 11731420 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.27 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.27 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.62 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
4.61 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
4.61 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.61 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.78 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.03 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
15.51 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
15.51 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
15.51 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
15.51 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.03 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.08 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.90 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.66 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.60 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.60 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
3.81 | 18072171 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.70 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
2.97 | 16810080 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.07 | 17484760 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.47 | 8041377 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.15 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.15 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.37 | 19410462 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.42 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.42 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.27 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.59 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.33 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
20.34 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Pilocarpine |
20.34 | 15987249 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
20.34 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
20.34 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.60 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
10.60 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
10.60 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.01 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.70 | 20387270 |
MESH:D009765 |
Obesity |
|
Clozapine |
5.02 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
olanzapine |
5.02 | 18515891 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
5.08 | 20418887 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.96 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.04 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.04 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.04 | 16936753 |
MESH:D010146 |
Pain |
|
Fluoxetine |
6.23 | 12798668 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.23 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.68 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
7.68 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.68 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.31 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Levodopa |
4.41 | 18328768 11432539 20334432 7566641 19594199 |
MESH:D020734 |
Parkinsonian Disorders |
|
Levodopa |
5.31 | 11246459 8817341 18722529 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.83 | 12520081 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
5.60 | 8041377 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.17 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.96 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
7.96 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.11 | 11118676 11896295 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.11 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.52 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.69 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.69 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.69 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.23 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.91 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.81 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.81 | 12752131 11422049 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
10.49 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
10.49 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
13.13 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
13.13 | 16134406 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
13.13 | 11575062 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.38 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.45 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.62 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.62 | 19155313 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18923069 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
7.39 | 19369910 20107430 20521320 20521326 16141801 17726453 20580759 20452607 20168265 18855531 11151749 11763009 17667964 17123785 18806925 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
7.39 | 1830565 19369910 20107430 18513383 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
7.39 | 17726453 20521326 20107430 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
7.39 | 15737665 19110320 |
MESH:C537537 |
Segawa syndrome, autosomal recessive |
|
Levodopa |
6.28 | 8817341 |
MESH:D012640 |
Seizures |
marker/mechanism |
|
| 8954991 |
MESH:D012640 |
Seizures |
|
Aminooxyacetic Acid |
28.29 | 1511512 |
MESH:D012640 |
Seizures |
|
Cocaine |
28.29 | 10454489 |
MESH:D012640 |
Seizures |
|
Diazepam |
28.29 | 9754883 15946322 10087439 |
MESH:D012640 |
Seizures |
|
Pentylenetetrazole |
28.29 | 3037702 8954991 18657176 15475178 19660546 16054440 18164287 3352866 2616065 6431079 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
28.29 | 3137016 4039156 11442880 16876388 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
28.29 | 8635557 8954991 |
MESH:D012640 |
Seizures |
|
Pilocarpine |
28.29 | 19660546 7750514 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
28.29 | 3137016 11738929 1511512 17978042 11044598 15475178 14763951 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.41 | 6407741 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.48 | 8704074 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.25 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.25 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
8.25 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.18 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.18 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.63 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.51 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.51 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Pilocarpine |
11.46 | 19430551 19951488 19055492 15987249 19570321 11259499 15857427 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
11.46 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.31 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.31 | 17261132 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Diazepam |
5.09 | 9754883 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
9.67 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
9.67 | 20210726 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.25 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.81 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.49 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
10.19 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
10.19 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
10.19 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.27 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.44 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.82 | 17262798 |
MESH:D014202 |
Tremor |
|
Pilocarpine |
5.39 | 17594079 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.97 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.11 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.55 | 11723127 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.55 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.24 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.24 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.24 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.92 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.20 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.02 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.18 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.18 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.67 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.83 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
9.21 | 16141801 17502770 16402076 20107430 20564506 20521320 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
9.21 | 20107430 17933447 19434072 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.67 | 17933447 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.63 | 16287080 |